Characteristics and pattern of childhood psoriasis in Saudi Arabia
Keywords:
Childhood psoriasis, Saudi Arabia, pattern of disease, NB-UVB phototherapyAbstract
Background Psoriasis is a chronic inflammatory, immunologically mediated disorder in which one-third of patients suffer under the 18 years of age (childhood psoriasis). Although, the exact pathogenesis of the disease is unknown but the clinical information on disease has been the significant value to understand the nature of disease. Patients and methods In this study, we present our experiences with 36 children having childhood psoriasis who visited the dermatology and phototherapy unit from January 1999 to December 2006. All the cases were diagnosed clinically. Results Of 36 children, 12 (33.3%) had the generalized (plaque type) psoriasis, 8 (22.2%) had the guttate psoriasis, 4 (11.1%) had the mixed guttate and plaque type; while 6 (16.7%) had the localized lesions on elbows and knees, 4 (11.1%) had the localized lesions on hands and feet and 1 (2.8%) had on scalp. One child (2.8%) had erythematous lesions all over the body since birth (congenital psoriasis). The age of children ranged from 8 months to 18 years (mean=11.27 years). The duration of the disease ranged from 2 months to 11 years (mean=3.04 years). The number of male patients was 15 and the females were 21, hence the male and female ratio was 1:1.4. The family history was positive in 10 (27.8%) children. All patients were treated by giving the various types of topical medications and/or narrow-band ultraviolet B phototherapy treatment. Conclusion Childhood psoriasis is more common in girls than in boys and plaque type psoriasis is the most common in Arabs. At present, the narrow-band ultraviolet-B phototherapy is safe and effective in moderate and severe cases especially in those children who do not respond to topical protocol treatments.References
Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009; 60: 218-24.
Silverberg NB. Pediatric psoriasis: an update. Ther Clin Risk Manag 2009; 5: 849-856.
Lehman JS, Rahil AK. Congenital psoriasis: Case report and literature review. Pediatr Dermatol 2008; 25: 332-8.
Morris A, Rogers M, Fischer G et al. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol 2001; 18: 188-198.
Li Y, Begovich AB, Unraveling the genetics of complex diseases; susceptibility genes for rheumatoid arthritis and psoriasis. Semin Immunol 2009; 46: 736-44.
Seyhan M, Coskun BK, Saglam H et al. Psoriasis in childhood and adolescence: Evaluation of demographic and clinical features. Pediatr Int 2006; 48: 525-30.
Cassandra M, Conte E, Cortez B. Childhood pustular psoriasis elicited by the streptococcal antigen: a case report and review of the literature. Pediatr Dermatol 2003; 20: 506-10.
Burden AD. Management of psoriasis in childhood. Clin Exp Dermatol 1999; 24: 341-5.
Kumar B, Jain R, Sandhu K et al. Epidemiology of childhood psoriasis: a study of 419 patients from northern India. Int J Dermatol 2004; 439: 654-8.
Fan X, Xiao FL, Yanq S et al. Childhood psoriasis: a study of 277 patients from China. J Eur Acad Dermatol Venereol 2007; 21: 762-765.
de Jager ME, de Jong EM, Meeuwis kA et al. No evidence found that childhood onset of psoriasis influences disease severity, future body mass index of type of treatments used. J Eur Acad Dermatol Venereol 2010; 24: 1333-9.
Lehners-Weber C, de la Brassinne M, Dezfoulian B et al. Congenital psoriasis following the lines of Blaschko. Pediatr Dermatol 1996; 13: 219-21.
Al-Fouzan SA, Hassab-El-Nabi HMM, Nanda A. Congenital linear psoriasis: a case report. Pediatr Dermatol 1990; 7: 303-6.
Lerner MR, Lerner AB. Congenital psoriasis: report of three cases. Arch Dermatol 1972; 105: 598-601.
Henriksen L, Zachariae H. Pustular psoriasis and arthritis in congenital psoriasiform erythroderma. Dermatologica 1972; 144: 12-8.
Oranje AP, Marcoux D, Svensson A et al. Topical calcipotriol in childhood psoriasis. J Am Acad Dermatol 1997; 36: 203-8.
Kimball AB, Gold MH, Zib B, Davis MW. Clobetasol propionate emulsion formulation foam phase III clinical study group. Clobetasol propionate emulsion formulation foam 0.05%: review of phase IIopen-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J am Acad Dermatol 2008; 59: 448-54.
Kiken DA, Silverberg NB. Atopic dermatitis in children, part 2: treatment options. Cutis 2006; 78: 401-6.
Farber EM, Nall L. Childhood psoriasis. Cutis 1999; 64: 309-14.
Jain VK, Aggarwal K, Jain K et al. Narrow-band UV-B phototherapy in childhood psoriasis. Int J Dermatol 2007; 46: 320-22.
Green C, Ferguson J, Lakshmipathi T et al. 311nm UVB phototherapy: an effective treatment of psoriasis. Br J Dermatol 1988; 119: 691-6.
Tanew A, Radakovic-Fijan S, Schemper M et al. Narrow band UVB phototherapy versus photochemotherapy in the treatment of chronic plaque type psoriasis: a paired comparison study. Arch Dermatol 1999; 135: 519-24.
Van Weelden H, Baart de la Faille H, Young E et al. Comparison of narrow-band UVB phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm-Venereol (Stockh) 1990; 70: 212-5.
Ersoy-Evans S, Altaykan A, Sahin S et al. Phototherapy in childhood. Clinical and laboratory investigations. Pediatric Dermatol 2008; 25: 599-605.
Al-Fouzan AS, Nanda A. UVB phototherapy in childhood psoriasis. Pediatr Dermatol 1995; 12: 66.
Jury CS, McHenry P, Burden AD et al. Narrow-band ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol 2006; 31: 196-9.
Tay YK, Morelli JG, Weston WL. Experience with UVB phototherapy in children. Pediatr Dermatol 1996; 13: 406-9.
Al-Suwaidan SN, Feldman S. Clearance is not a realistic expectation of psoriasis treatment. J Am Acad Dermatol 2000; 42: 796-802.
